These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1531952)

  • 41. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure].
    Riegger AJ
    Klin Wochenschr; 1991; 69 Suppl 24():20-3. PubMed ID: 1830909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular effects of dobutamine and converting enzyme inhibition in rats with diabetic ketoacidosis.
    Charocopos F; Gavras H
    Pharmacology; 1985; 30(2):65-70. PubMed ID: 2983358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic-pharmacodynamic model relating lisinopril plasma concentrations to regional hemodynamic effects in healthy volunteers.
    Bellissant E; Nguyen PC; Giudicelli JF
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):470-8. PubMed ID: 8877596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin-converting enzyme inhibitors in cardiovascular anesthesia.
    Colson P
    J Cardiothorac Vasc Anesth; 1993 Dec; 7(6):734-42. PubMed ID: 8305666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium blocker lacidipine and carotid arteriolar vasodilation in healthy volunteers.
    Safar M; Bons J; Georges D; Cournot A; Duchier J
    Clin Pharmacol Ther; 1989 Jul; 46(1):94-8. PubMed ID: 2663319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic-pharmacodynamic model relating zabiciprilat plasma concentrations to brachial and femoral haemodynamic effects in normotensive volunteers.
    Bellissant E; Giudicelli JF
    Br J Clin Pharmacol; 1998 Oct; 46(4):383-93. PubMed ID: 9803988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic and renal haemodynamic effects of angiotensin converting enzyme inhibition by zabicipril in young and in old normal men.
    Naeije R; Fiasse A; Carlier E; Opsomer M; Leeman M
    Eur J Clin Pharmacol; 1993; 44(1):35-9. PubMed ID: 8436152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers.
    Démolis P; Annane D; Duhazé P; Giudicelli JF
    Fundam Clin Pharmacol; 1994; 8(1):80-9. PubMed ID: 8181800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man.
    MacDonald NJ; Hughes DM; Lees KR; Reid JL
    Br J Clin Pharmacol; 1990 Jul; 30(1):107-13. PubMed ID: 2202384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.
    Gohlke P; Stoll M; Lamberty V; Mattfeld T; Mall G; van Even P; Martorana P; Unger T
    J Hypertens Suppl; 1992 Aug; 10(6):S141-4. PubMed ID: 1432317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic and regional hemodynamic effects of zabicipril in healthy volunteers.
    Bellissant E; Thuillez C; Pussard E; Giudicelli JF
    Clin Pharmacol Ther; 1992 Mar; 51(3):308-19. PubMed ID: 1531952
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.